Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
COMPASS Pathways Plc - American Depository Shares
(NQ:
CMPS
)
6.675
-0.055 (-0.82%)
Streaming Delayed Price
Updated: 11:21 AM EST, Dec 30, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about COMPASS Pathways Plc - American Depository Shares
< Previous
1
2
...
10
11
12
13
14
15
16
17
18
...
30
31
Next >
Top 3 Psychedelic Storylines To Watch In 2023
↗
January 29, 2023
This article by James Hallifax was originally published on Microdose and appears here with permission.
Via
Benzinga
Largest Psychedelic Stocks +1.2% This Week; Now +16.1% YTD
↗
January 28, 2023
We track the 6 largest psychedelic stocks that research the treatment of mental illnesses based on the use of one or more psychedelic substances - weekly and YTD results.
Via
Talk Markets
Cybin, GH Research Among Top Psychedelic Movers Of Today
↗
January 27, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 26, 2023
↗
January 26, 2023
Via
Benzinga
Psychedelic-Derived Medicines for Neurologic Conditions Fueling Large Revenue Growth in Projected $4 Billion Dollar Industry
January 26, 2023
EQNX::TICKER_START (OTCQB:LOBEF),(NASDAQ:ATAI),(NASDAQ:CMPS),(NYSE:CYBN),(NASDAQ:MNMD) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Economy
Psychedelic Stock Gainers And Losers From January 17, 2023
↗
January 17, 2023
Via
Benzinga
Biomind Labs, Intelgenx Technologies Among Top Psychedelic Movers Of Today
↗
January 25, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 24, 2023
↗
January 24, 2023
Via
Benzinga
Atai Life Sciences Investor Christian Angermayer Addresses Recent Trial Results And Pipeline Outlook
↗
January 24, 2023
In our latest Trade To Black Podcast, TDR Founder Shadd Dales and lead financial writer Benjamin A. Smith interview the founder of Apeiron Investment Group, Christian Angermayer.
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 23, 2023
↗
January 23, 2023
Via
Benzinga
Largest Psychedelic Stocks +3% This Week; Now +15% YTD
↗
January 21, 2023
Our Psychedelic Drug Stocks Index tracks the six largest psychedelic stocks, by market capitalization, that research the treatment of mental illnesses based on the use of one or more of 10 different...
Via
Talk Markets
Mind Medicine, Seelos Therapeutics Among Top Psychedelic Movers Of Today
↗
January 20, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 11, 2023
↗
January 11, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 10, 2023
↗
January 10, 2023
Via
Benzinga
ATAI Life Sciences, Cybin Among Top Psychedelic Movers Of Today
↗
January 06, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 19, 2023
↗
January 19, 2023
Via
Benzinga
Psychedelics Market Could Reach $12B By 2029, Says New Report
↗
January 19, 2023
A new analysis of the global market for psychedelics performed by Brandessence Market Research shows an expected growth from 2022’s $4.87 billion to an annual valuation of nearly $12 billion before...
Via
Benzinga
Mind Medicine, Seelos Therapeutics Among Top Psychedelic Movers Of Today
↗
January 18, 2023
Via
Benzinga
Psychedelics Company Numinus Wellness Consolidates Recent Surge Higher: What's Going On?
↗
January 18, 2023
Numinus Wellness, Inc (OTC: NUMIF) was consolidating about 2% lower on Wednesday after surging over 30% on Tuesday.
Via
Benzinga
Psychedelic Drug Developer Mindset Pharma Optimistic About 2023 After Key 2022 Funding Collaborations And Patent Allowances
↗
January 18, 2023
Once considered the realm of ancient civilizations and countercultures, psychedelics have in the past few years been seeing increasing interest.
Via
Benzinga
Psyched: Psychedelics In Davos, Prince Harry In The 90s, Cathie Wood's Latest Moves And More
↗
January 17, 2023
Psychedelics Take Center Stage In Davos Psychedelics will lead the conversation inside the Davos House of Health for a second year in a row this January.
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 5, 2023
↗
January 05, 2023
Via
Benzinga
Seelos Therapeutics, Cybin Among Top Psychedelic Movers Of Today
↗
January 04, 2023
Via
Benzinga
Vistagen Poised To Begin Phase 1 Trial Of A Fast-Acting Antidepressant Nasal Spray In First Quarter Of 2023
↗
January 17, 2023
In the race to create faster-acting, safer antidepressants, Vistagen (NASDAQ: VTGN) is starting the year strong as it gets ready to launch a Phase 1 Trial of its novel pherine nasal spray for Major...
Via
Benzinga
GH Research, Cybin Among Top Psychedelic Movers Of Today
↗
January 16, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 13, 2023
↗
January 13, 2023
Via
Benzinga
Intelgenx Technologies, Cybin Among Top Psychedelic Movers Of Today
↗
January 12, 2023
Via
Benzinga
Cathie Wood Reacts To Atai's Drastic Stock Plunge After Doomed Clinical Study Results
↗
January 12, 2023
After atai Life Sciences (NASDAQ: ATAI) shared the results of subsidiary Perception Neuroscience’s Phase 2 trial of R-ketamine compound for TRD, the psyche
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 9, 2023
↗
January 09, 2023
Via
Benzinga
My "Rags-To-Riches" Portfolio For 2023: An Introduction
↗
January 08, 2023
The performance of cannabis, psychedelic and plant-based food stocks in 2022 were just horrible; is there any way to go but up?
Via
Talk Markets
< Previous
1
2
...
10
11
12
13
14
15
16
17
18
...
30
31
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
